Aflibercept for Macular Oedema With Underlying Retinitis Pigmentosa (AMOUR) Study

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions
Macular OedemaRetinitis Pigmentosa
Interventions
DRUG

Aflibercept

"2mg of 40mg/ml of Eylea Solution administered via intravitreal injection every four weeks for three months (loading dose), followed by a treat and extend protocol up to 12 months. Extension from monthly to 6, 8, 10 and 12 week follow up will occur where there is no reduction in macula oedema compared with the previous visit.~Number of cycles; minimum of 5 injections and maximum of 13 injections per study eye."

Trial Locations (1)

EC1V 2PD

Moorfields Eye Hospital, London

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Moorfields Eye Hospital NHS Foundation Trust

OTHER